Bridging the treatment gap in patients at ‘extreme’ cardiovascular risk: Evidence from a lipid clinic

Rallidis et al. evaluated whether achieving low-density lipoprotein cholesterol (LDL-C) less than 55 mg/dL in patients at ‘extreme’ cardiovascular disease (CVD) risk is feasible in clinical practice [ [1] Rallidis L.S. Kiouri E. Katsimardos A. et al. Extreme-risk category: high prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55mg/dL. Atherosclerosis. 2018; 275: 262-264...